Hong Kong medical journal = Xianggang yi xue za zhi / Hong Kong Academy of Medicine
-
Multicenter Study
Hong Kong's experience on the use of extracorporeal membrane oxygenation for the treatment of influenza A (H1N1).
To report Hong Kong's experience on the use of extracorporeal membrane oxygenation for the treatment of acute respiratory distress syndrome caused by influenza A (H1N1). ⋯ In response to the pandemic of influenza A (H1N1), some intensive care units in Hong Kong were able to offer extracorporeal membrane oxygenation to selected cases. In this small series, patient outcomes were similar to those reported in other observational studies, indicating that intensive care units in Hong Kong are capable of successfully introducing this technology. However, the cost-effectiveness and optimal delivery of this strategy remain uncertain.